| [1-11C]-Butanol Positron Emission Tomography reveals an impaired brain to nasal turbinates pathway in aging amyloid positive subjects NH Mehta, X Wang, SA Keil, K Xi, L Zhou, K Lee, W Tan, E Spector, ... Fluids and Barriers of the CNS 21 (1), 30, 2024 | | 2024 |
| [IC‐P‐041]: SAMPLE SIZES FOR 24‐MONTH ALZHEIMER's PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID‐POSITIVE ADULTS EM Reiman, X Kuang, J Luo, Y Chen, P Thiyyagura, R Bauer III, W Lee, ... Alzheimer's & Dementia 13 (7S_Part_1), P36-P37, 2017 | 1 | 2017 |
| [IC‐P‐209]: CAVEATS WHEN SUBTRACTING TWO SERIAL MEASUREMENTS TO ESTIMATE THE NUMBER OF PARTICIPANTS NEEDED FOR CLINICAL TRIALS THAT ARE LONGER OR SHORTER THAN THE OBSERVED … K Chen, C Xiong, D Harvey, X Guo, M Weiner, WJ Jagust, EM Reiman Alzheimer's & Dementia 13 (7S_Part_3), P151-P152, 2017 | | 2017 |
| [IC‐P‐210]: LEFT LATERALIZED CEREBRAL GLUCOSE METABOLISM DECLINES IN AMYLOID‐β–POSITIVE SUBJECTS WITH MILD COGNITIVE IMPAIRMENT CM Weise, K Chen, X Kuang, C Savage, EM Reiman Alzheimer's & Dementia 13 (7S_Part_3), P152-P152, 2017 | | 2017 |
| [IC‐P‐211]: A COMPUTATIONAL MONTE CARLO SIMULATION STRATEGY TO COMPARE THE ONSET OF DIFFERENT BIOMARKER AND COGNITIVE CHANGES K Chen, Y Chen, C Xiong, EM Reiman Alzheimer's & Dementia 13 (7S_Part_3), P152-P153, 2017 | | 2017 |
| [O1–12–02]: PROGRESSION FROM PRECLINICAL AD TO MCI OVER A DECADE: COGNITIVE AND BRAIN IMAGING TRAJECTORIES RJ Caselli, K Chen, Y Chen, P Thiyyagura, X Kuang, R Bauer III, ... Alzheimer's & Dementia 13 (7S_Part_4), P222-P222, 2017 | | 2017 |
| [O1–13–02]: COGNITIVE VULNERABILITIES IN PRESENILIN‐1 E280A MUTATION‐CARRYING CHILDREN FROM THE WORLD's LARGEST AUTOSOMAL‐DOMINANT ALZHEIMER's DISEASE KINDRED YT Quiroz, M Pulsifer, K Chen, D Ramirez, N Londono, ... Alzheimer's & Dementia 13 (7S_Part_4), P225-P226, 2017 | 2 | 2017 |
| [P‐121]: Resting FDG‐PET in neurologically normal individuals reporting dream enactment behavior: Preclinical dementia with lewy bodies? RJ Caselli, EM Reiman, K Chen, GE Alexander, D Osborne, J Parish, ... Alzheimer's & Dementia 1, S47-S48, 2005 | | 2005 |
| [P1–030]: RELATIONSHIPS BETWEEN MEMORY FUNCTION, TAU PATHOLOGY AND FUNCTIONAL CONNECTIVITY IN THE DEFAULT MODE NETWORK IN AUTOSOMAL‐DOMINANT ALZHEIMER's DISEASE: A PRELIMINARY … E Guzman‐Velez, G Castrillon, K Chen, D Norton, A Baena, ... Alzheimer's & Dementia 13 (7S_Part_5), P245-P245, 2017 | | 2017 |
| [P1–261]: TRACKING ALZHEIMER's DISEASE PROGRESSION BY NON‐LINEAR DIMENSION REDUCTION OF BRAIN MRI FEATURES K Seo, R Pan, K Chen, P Thiyyagura Alzheimer's & Dementia 13 (7S_Part_7), P349-P350, 2017 | 1 | 2017 |
| [P2–333]: CAVEATS WHEN SUBTRACTING TWO SERIAL MEASUREMENTS TO ESTIMATE THE NUMBER OF PARTICIPANTS NEEDED FOR CLINICAL TRIALS THAT ARE LONGER OR SHORTER THAN THE OBSERVED … K Chen, C Xiong, D Harvey, X Guo, M Weiner, WJ Jagust, EM Reiman Alzheimer's & Dementia 13 (7S_Part_15), P748-P748, 2017 | | 2017 |
| [P2–434]: INTELLECTUAL FUNCTION VERSUS YEARS OF EDUCATION AS COGNITIVE RESERVE PROXIES: INTERACTION WITH ALZHEIMER's DISEASE NEUROPATHOLOGY AND IMPACT ON EPISODIC MEMORY AND … M Malek‐Ahmadi, S Lu, YY Chan, SE Perez, K Chen, EJ Mufson Alzheimer's & Dementia 13 (7S_Part_16), P802-P802, 2017 | 1 | 2017 |
| [P3–032]: SSRI USE ASSOCIATED WITH REDUCED AMYLOID BURDEN IN PERSONS WITH COMBAT‐RELATED PTSD: PRELIMINARY FINDINGS FROM ADNI‐DOD DD Goradia, K Chen, Y Chen, N Snyder, D Harvey, SM Landau, ... Alzheimer's & Dementia 13 (7S_Part_19), P942-P942, 2017 | | 2017 |
| [P4–247]: LEFT LATERALIZED CEREBRAL GLUCOSE METABOLISM DECLINES IN AMYLOID‐β‐POSITIVE SUBJECTS WITH MILD COGNITIVE IMPAIRMENT CM Weise, K Chen, X Kuang, C Savage, EM Reiman Alzheimer's & Dementia 13 (7S_Part_28), P1372-P1372, 2017 | | 2017 |
| [P4–474]: ASSESSING POTENTIALS OF PLASMA AMYLOID BETA 42 AND TAU LEVELS FOR ALZHEIMER'S DISEASE DIAGNOSIS BY TESTING IMMUNOMAGNETIC REDUCTION TECHNOLOGY IN A SUN CITY COHORT LF Lue, MN Sabbagh, A Guerra, DG Walker, K Chen, EM Reiman Alzheimer's & Dementia 13 (7S_Part_31), P1515-P1515, 2017 | | 2017 |
| [P4–503]: IMPROVED PREDICTION OF PROGRESSION TO CLINICAL STAGES OF ALZHEIMER's DISEASE USING MULTIVARIATE SURFACE MORPHOMETRY OF MRI BIOMARKERS AND PATCH‐BASED SPARSE CODING J Zhang, Y Wang, Q Li, J Shi, R Bauer III, EM Reiman, RJ Caselli, K Chen, ... Alzheimer's & Dementia 13 (7S_Part_32), P1532-P1532, 2017 | | 2017 |
| 1053-8119/00/$–see front matter© 2003 Elsevier Science (USA). All rights reserved. J Aerts, JA Agnew, H Alkadhi, MT Alkire, CM Anderson, SJ Anderson, ... NeuroImage 20, 2357-2361, 2003 | | 2003 |
| 11C-CFT-PET in presymptomatic FTDP-17: a potential biomarker predicting onset L Wu, J Liu, X Feng, J Dong, W Qin, Y Liu, J Wang, J Lu, K Chen, Y Wang, ... Journal of Alzheimer's Disease 61 (2), 613-618, 2018 | 12 | 2018 |
| 13N-Ammoniaand PET: Comparison Y Choi, SC Huang, RA Hawkins, JY Kim, BT Kim, CK Hoh, K Chen, ... | | |
| 18F-florbetapir Positron Emission Tomography–determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery RY Klinger, OG James, S Borges-Neto, T Bisanar, YJ Li, W Qi, M Berger, ... Anesthesiology 128 (4), 728-744, 2018 | 32 | 2018 |
Eric ReimanBanner Alzheimer's Institute在 bannerhealth.com 的电子邮件经过验证
